|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,278 JPY | +2.29% |
|
+3.15% | +37.53% |
| 10/07 | Jefferies Adjusts Otsuka Holdings' Price Target to 8,100 Yen From 7,800 Yen, Keeps at Buy | MT |
| 09/07 | Indivior shares dive on profit warning, dropping of schizophrenia drug (July 9) | RE |
Company name Otsuka Holdings Co., Ltd. Representative Tatsuo Higuchi
President and Representative Director, CEO Code number 4578 First Section, Tokyo Stock Exchange
Inquiries Takuma Kimura
Director, Investors Relations Department
Antipsychotic Agent ABILIFY® Receives Regulatory Approvals for Additional Indication "Improvement of Manic Symptoms Associated with Bipolar Disorder" and for New Dosage Form "ABILIFY® OD Tablets"
| 1st Jan change | Capi. | |
|---|---|---|
| +37.53% | 2.43TCr | |
| +25.40% | 4.53TCr | |
| +27.12% | 1.65TCr | |
| +21.19% | 1.46TCr | |
| +71.91% | 1.43TCr | |
| -0.05% | 678.76Cr | |
| -11.57% | 656.86Cr | |
| +15.08% | 576.04Cr | |
| -8.87% | 572.55Cr | |
| +35.91% | 501.47Cr |
OTSUKA HOLDINGS CO., LTD. 
By 
